Impact of COVID-19 and TB co-infection on global patients in the pandemic situation: an update review
Paper Details
Impact of COVID-19 and TB co-infection on global patients in the pandemic situation: an update review
Abstract
COVID-19 has been emerged as a deadly disease due to its immense severity to human beings around the world. The World Health Organization (WHO) has declared this prevalence as pandemic because of the diversified natures of corona virus. People of all ages, mainly elderly people having various medical conditions and pregnant women are the most vulnerable groups for SARS-CoV-2 infection. This epidemic condition has made serious consequences for global health and socio-economic condition. Tuberculosis (TB) is another life threatening chronic disease that affects patients severely in their lungs. Synergistic effects of TB and COVID-19 aggravate the mortality rate of co-infected patients as both of the diseases manifest in the respiratory systems and show very similar signs and symptoms. Even, the modes of transmission of these diseases occur via spreading of droplets from infected persons to healthy persons. Therefore, the aim of this review is to describe update information on co-infection relation, diagnosis, prevention and control measures associated with TB and COVID-19 in order to manage this pandemic situation early and effectively.
Albert, Heidi. 2020. “Designing an Optimized Diagnostic Network to Improve Access to TB Diagnosis and Treatment in Lesotho. Plos one 15(6), e0233620.
Bandyopadhyay, Arkapal, Sarika Palepu, Krishna Bandyopadhyay, Shailendra Handu. 2020. “COVID-19 and Tuberculosis Co-Infection: A Neglected Paradigm.” Monaldi Archives for Chest Disease 90(3).
Caruana, Giorgia. 2020. “Diagnostic Strategies for SARS-CoV-2 Infection and Interpretation of Microbiological Results.” Clinical Microbiology and Infection.
Christof, Claudia, Barbara Nussbaumer-Streit, Gerald Gartlehner. 2020. “WHO Guidelines on Tuberculosis Infection Prevention and Control.” Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)).
Filgueiras, Alberto, Matthew Stults-Kolehmainen. 2020. “Factors Linked to Changes in Mental Health Outcomes among Brazilians in Quarantine Due to COVID-19.” medRxiv.
Gilpin, Christopher. 2018. “The World Health Organization Standards for Tuberculosis Care and Management.”
Gordon, David E. 2020. “A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug Repurposing.” Nature: 1–13.
Hameed HM. 2018. “Molecular Targets Related Drug Resistance Mechanisms in MDR-, XDR-, and TDR-Mycobacterium Tuberculosis Strains.” Frontiers in cellular and infection microbiology 8, 114.
Islam, Md Mahmudul. 2017. “Drug Resistance Mechanisms and Novel Drug Targets for Tuberculosis Therapy.” Journal of genetics and genomics 44(1): 21–37.
Liu, Wei. 2006. “Pulmonary Tuberculosis and SARS, China.”
Liu, Weiyong. 2020. “Detection of Covid-19 in Children in Early January 2020 in Wuhan, China.” New England Journal of Medicine 382(14), 1370–71.
Lu, Roujian. 2020. “Genomic Characterisation and Epidemiology of 2019 Novel Coronavirus: Implications for Virus Origins and Receptor Binding.” The Lancet 395(10224), 565–74.
Mendy, Joseph 2019. “Changes in Mycobacterium Tuberculosis-Specific Immunity with Influenza Co-Infection at Time of TB Diagnosis.” Frontiers in Immunology 9, 3093.
Nathavitharana, Ruvandhi R, Jon S, Friedland. 2015. “A Tale of Two Global Emergencies: Tuberculosis Control Efforts Can Learn from the Ebola Outbreak.”
Organization, World Health. 2011. Commercial Serodiagnostic Tests for Diagnosis of Tuberculosis: Policy Statement. World Health Organization.
Global Tuberculosis Report. 2013. World Health Organization.
WHO Guidelines on Tuberculosis Infection Prevention and Control. 2019. Update. World Health Organization.
Assessment Tool for Laboratories Implementing. 2020. COVID-19 Virus Testing: Interim Guidance, 8 April 2020. World Health Organization.
Coronavirus Disease. 2020. (COVID-19) Outbreak: Rights, Roles and Responsibilities of Health Workers, Including Key Considerations for Occupational Safety and Health.” World Health Organization, Interim guidance 19.
Diagnostic Testing for SARS-CoV-2: Interim Guidance, 11 September. 2020. World Health Organization.
Final Report on Implementation of the Tuberculosis Action Plan for the WHO. 2020. European Region 2016–2020.
Health System Considerations: When Influenza Meets COVID-19: Preparedness and Response Measures When COVID-19, Influenza and Acute Respiratory Infections Coincide in the WHO European Region, Revised Version December. 2020. World Health Organization. Regional Office for Europe.
Infection Prevention and Control during Health Care When Novel Coronavirus. 2020. ( NCoV) Infection Is Suspected: Interim Guidance, 25 January 2020.
Infection Prevention and Control Guidance for Long-Term Care Facilities in the Context of COVID-19. 2020. Interim Guidance, 21 March 2020. World Health Organization.
Laboratory Testing Strategy Recommendations for. 2020. COVID-19: Interim Guidance, 22 March 2020. World Health Organization.
WHO. 2020. Consolidated Guidelines on Tuberculosis: Module 3: Diagnosis–Rapid Diagnostics for Tuberculosis Detection: Web Annex 4: Evidence Synthesis and Analysis.
World Health Organization Coronavirus Disease. 2020. (COVID-19) Dashboard.
Prevention, Centers for Disease Control. 2017. “HIV Continuum of Care, US, 2014, Overall and by Age, Race/Ethnicity, Transmission Route and Sex.”
Centers for Disease Control and Prevention Coronavirus Disease. 2019. (COVID-19) 2020.
Soares, Samira Silva Santos. 2020. “Pandemia de Covid-19 e o Uso Racional de Equipamentos de Proteção Individual [Covid-19 Pandemic and Rational Use of Personal Protective Equipment] [Pandemia de Covid-19 y Uso Racional de Equipos de Protección Personal].” Revista enfermagem uerj 28, 50360.
Tadolini, Marina. 2020. “Active Tuberculosis, Sequelae and COVID-19 Co-Infection: First Cohort of 49 Cases.” European Respiratory Journal.
Tang, Xiujuan. 2020. “Positive RT-PCR Tests among Discharged COVID-19 Patients in Shenzhen, China.” Infection Control & Hospital Epidemiology: 1–2.
Tenforde, Mark W. 2020. “Symptom Duration and Risk Factors for Delayed Return to Usual Health among Outpatients with COVID-19 in a Multistate Health Care Systems Network—United States, March–June 2020.” Morbidity and Mortality Weekly Report 69(30), 993.
Vandenberg, Olivier. 2020. “Considerations for Diagnostic COVID-19 Tests.” Nature Reviews Microbiology, 1–13.
Walaza, Sibongile. 2015. “Influenza Virus Infection Is Associated with Increased Risk of Death amongst Patients Hospitalized with Confirmed Pulmonary Tuberculosis in South Africa, 2010–2011.” BMC infectious diseases 15(1), 26.
Yang, Heng, Shuihua Lu. 2020. “COVID-19 and Tuberculosis.” Journal of Translational Internal Medicine 8(2), 59–65.
Yao, Zhi. 2020. “Three Patients with COVID-19 and Pulmonary Tuberculosis, Wuhan, China, January–February 2020.” Emerging infectious diseases 26(11), 2754.
Sumon Chandro Mohanto, Md. Sohanur Rahman Sohan, 2021. Impact of COVID-19 and TB co-infection on global patients in the pandemic situation: an update review. Int. J. Biosci., 18(1), 171-177.
Copyright © 2021 by the Authors. This article is an open access article and distributed under the terms and conditions of the Creative Commons Attribution 4.0 (CC BY 4.0) license.